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In Brief
Contrary to a recent report suggesting
that a preadolescent burst of
cardiomyocyte proliferation promotes
heart growth, cardiomyocyte number
expansion appears limited to the
neonatal period, with cardiomyocyte
hypertrophy likely accounting for the
increase in the heart size.
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The magnitude of cardiomyocyte generation in the
adult heart has been heavily debated. A recent report
suggests that duringmouse preadolescence, cardio-
myocyte proliferation leads to a 40% increase in the
number of cardiomyocytes. Such an expansion
would change our understanding of heart growth
and have far-reaching implications for cardiac regen-
eration. Here, using design-based stereology, we
found that cardiomyocyte proliferation accounted
for 30% of postnatal DNA synthesis; however, we
were unable to detect any changes in cardiomyocyte
number after postnatal day 11. 15N-thymidine and
BrdU analyses provided no evidence for a prolifera-
tive peak in preadolescent mice. By contrast, cardio-
myocyte multinucleation comprises 57% of post-
natal DNA synthesis, followed by cardiomyocyte
nuclear polyploidisation, contributing with 13% to
DNA synthesis within the second and third postnatal
weeks. We conclude that the majority of cardiomyo-
cytes is set within the first postnatal week and that
this event is followed by twowaves of non-replicative
DNA synthesis. This Matters Arising paper is in
response to Naqvi et al. (2014), published in Cell.
See also the associated Correspondence by Soon-
paa et al. (2015), and the response by Naqvi et al.
(2015), published in this issue.INTRODUCTION
The replacement of cardiomyocytes has been a major challenge
in regenerative medicine. The neonatal mouse heart exhibits
robust myogenesis after apical resection and ischemic lesions;
this myogenesis is mainly mediated by duplication of preexisting
cardiomyocytes (Ali et al., 2014; Porrello et al., 2011; Puente
et al., 2014), although there is also evidence for a contribution
of precursor cells (c-kit-positive) to the regenerating myocar-
dium (Jesty et al., 2012). This regenerative process seems to
be limited to the first postnatal week (Puente et al., 2014), which1026 Cell 163, 1026–1036, November 5, 2015 ª2015 Elsevier Inc.coincides with an increase in binucleation in cardiomyocytes
(Soonpaa et al., 1996; Walsh et al., 2010). Senyo et al. evaluated
the degree of cardiomyocyte proliferation via the detection of the
non-radioactive isotope 15N-thymidine in dividing cardiomyo-
cytes. They observed limited myogenesis in both young and
old mice, with annual proliferation rates of less than 1% (Senyo
et al., 2013), in agreement with the human cardiomyocyte
renewal rates established by 14C birth dating (Bergmann et al.,
2009; 2015)
In contrast to these findings, Naqvi et al. (2014) reported a sec-
ond wave of cardiomyocyte proliferation during preadolescence
that occurs in a highly synchronized fashion. Most cardiomyo-
cytes re-entered the cell cycle starting on the evening of post-
natal day 14, followed by mitosis and cytokinesis on postnatal
day 15. This proliferative event remarkably increased the cardio-
myocyte count by 40%. As most cardiomyocytes are binucle-
ated at this stage, the authors suggested a model in which
binucleated cardiomyocytes undergo karyokinesis, resulting in
tetranucleated cardiomyocytes, followed by cytokinesis to
generate two mononucleated cardiomyocytes and one binucle-
ated cardiomyocyte. These replicative events were suggested to
be mediated by thyroid hormone (T3) through the IGF-1/Akt
pathway. These observations were provocative because
another recent study demonstrated that the increase in oxygen
at birth induces DNA damage, leading to cell-cycle arrest in car-
diomyocytes shortly after birth (Puente et al., 2014). The findings
reported by Naqvi et al. suggest a more complex regulation of
cardiomyocyte proliferation and consequently have major impli-
cations for the understanding of cardiomyocyte proliferation
(Palpant and Murry, 2014; Zhang and Ku¨hn, 2014). We have
re-examined their key observations, using both similar and alter-
native approaches. We observed that cardiomyocyte expansion
is restricted mainly to the first postnatal week, seriously chal-
lenging the reported contribution of cardiomyocyte proliferation
to the growing preadolescent mouse heart. Instead, we
observed that, in addition to multinucleation, murine cardiomyo-
cytes undergo polyploidization in the second and third postnatal
weeks. This time period corresponds well to the increase in
ploidy in human preadolescent hearts (Bergmann et al., 2009;
Mollova et al., 2013). This study also supports recent reports of
substantial early postnatal cardiomyogenesis without finding
any evidence for a second wave of cardiomyocyte proliferation
contributing to heart growth.
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Figure 1. Expansion of the Pool of Cardio-
myocytes in Neonatal Mouse Hearts
(A) The labeling strategy used to unequivocally
identify cardiomyocyte nuclei and the number of
nuclei per cardiomyocyte. Cardiomyocyte nuclei
were labeled with antibodies against PCM-1
(green), and the cardiomyocyte cell borders were
labeled with antibodies against connexin43 (Cx43)
and dystrophin (DMD) (red). The scale bar in-
dicates 20 mm.
(B) The cardiomyocyte density decreased during
heart growth from P2 to P100.
(C) The number of cardiomyocyte nuclei plateaued
around P11 and remained constant thereafter
(n = 3 to 6 for all analyzed time points).
(D) The process of multinucleation began early in
the neonatal period. At P9, most cardiomyocytes
already contained two or more nuclei.
(E) Stereological analysis revealed that the number
of cardiomyocytes increased in the early neonatal
period from 1.7 3 106 on P2 to 2.26 3 106 on P5
and reach a plateau on P11 (95% confidence in-
terval (blue), 95% prediction interval (red)).
(F) The results of the volume analysis of isolated
cardiomyocytes on P11 and P21. The upper panel
shows cardiomyocytes isolated on P11 (yellow)
and P21 (red) rendered by the Imaris software to
obtain their individual volumes (n = 3 for both
groups, total of 274 cardiomyocytes analyzed).
Scale bars,10 mm. Note the different lengths of the
scale bars in the images of cardiomyocytes from
P11 and P21. The left ventricle (black bars)
increased 2.0-fold between P11 and P21, com-
parable to the increase in the average car-
diomyocyte volume (gray bars) (right). * indicates
p < 0.05; ** indicates p < 0.001; NS: not significant.
All error bars indicate SD.RESULTS
The Final Number of Cardiomyocytes Is Mainly
Established within the First Postnatal Week
We determined the number of cardiomyocytes by stereology in
mouse hearts from postnatal day 2 (P2) to postnatal day 100
(P100) (Figure 1). The identification of cardiomyocyte nuclei in
tissue sections is challenging, particularly in the perinatal
period when the cell density is very high (Ang et al., 2010;
Soonpaa and Field, 1998). To circumvent this problem, we
used antibodies against the cardiomyocyte nuclear marker
pericentriolar material 1 (PCM-1) (Figure 1A) (Bergmann and
Jovinge, 2012; Bergmann et al., 2011; Gilsbach et al., 2014).
We obtained the mass of the left ventricle by weighting the
left ventricle including the septum (Figures S1A and S1B).
The reference volume was calculated using the tissue density
of the myocardium (1.06 g/cm3) (Bru¨el and Nyengaard, 2005).
The density of myocyte nuclei gradually decreased from
367,504 ± 42,055/mm3 (mean ± SD) on P2 to 128,983 ±
13,555/mm3 on P20 and 55,085 ± 10,574/mm3 on P100
(Figure 1B).Next, we established the number of postnatal cardiomyocyte
nuclei (Experimental Procedures). The number of cardiomyocyte
nuclei expanded continuously between P2 (1.87 3 106 ± 0.20 3
106) and P11 and plateaued thereafter (4.75 3 106 ± 1.04)
(ANOVA, post hoc Holm-Sidak, p > 0.05) (Figure 1C). The ratio
of mono- to multinucleated cardiomyocytes changed substan-
tially during the first 10 postnatal days. On P2, the majority
(93.2% ± 4.4%) of cardiomyocytes remained mononucleated,
in agreement with previous studies, whereas on P11, only
20.2% ± 2.2% were mononucleated, and 78.4% ± 1.5% were
binucleated. We did not observe any further changes in this ratio
between P11 and P100 (Figure 1D). Taking multinucleation into
account, we established that cardiomyocytes expanded by
approximately 40% between P2 (1.7 3 106 ± 0.2 3 106) and P5
(2.3 3 106 ± 0.2 3 106) (ANOVA, post hoc t test with Holm-Bon-
ferroni correction, p < 0.05) and then plateaued on P11 (2.6 3
106 ± 0.63 106) and remained constant at least until P100 (linear
regression, R = 0.016, p = 0.935, Figures 1E and S1C).
To investigate the contribution of the increase in cardiomyo-
cyte volume to the preadolescent growth of the left ventricle
(Leu et al., 2001), we determined the average volume ofCell 163, 1026–1036, November 5, 2015 ª2015 Elsevier Inc. 1027
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Figure 2. Cardiomyocyte DNA Synthesis in the Growing Mouse Heart
(A) Two EdU pulses were given on 2 consecutive days. Mice were sacrificed after a 24-hr chase period.
(B) EdU incorporation was detected in cardiomyocyte nuclei by co-labeling with PCM-1, and connexin43 (Cx43) and dystrophin (DMD) staining were used to
delineate cell borders. Arrows indicate EdU-positive cardiomyocyte nuclei. The scale bars, 10 mm.
(C) The postnatal DNA synthesis in cardiomyocytes was highest in mice sacrificed on P7 (17%), and rapidly declined thereafter to values below 1% on P15
(n = 3–4, for all analyzed time points).
(D) Mononucleated cardiomyocytes incorporated most of the EdU on P3, but by P7, most cardiomyocytes were bi- or multinucleated. The relative increase in the
number of mononucleated EdU-positive cardiomyocytes on P13 may be related to the increase in nuclear ploidy (Figure 3). ** indicates p < 0.001.
All error bars indicate SD.cardiomyocytes on day P11 (4,530 mm3 ± 1,410 mm3) and P21
(8,820 mm3 ± 3,120 mm3) (t test, p < 0.01) (Figure 1F and Experi-
mental Procedures). We determined that the 2.0-fold increase in
the volume of the left ventricle (P11: 20.1 ± 1.3 mm3 and P21:
40.8 ± 1.6 mm3) could be fully explained by the volume increase
(2.0-fold) of cardiomyocytes, indicating mainly hypertrophic
growth of the left ventricle and establishment of the full comple-
ment of cardiomyocytes by P11.
Postnatal DNA Synthesis Changes Mononucleated
Cardiomyocytes into Multinucleated Cardiomyocytes
The mice were treated with the thymidine analog EdU on two
consecutive days and sacrificed one day after the second treat-
ment (Figure 2A). The frequency of EdU incorporation was
determined by co-labeling with antibodies against cardiomyo-
cyte nuclei (PCM-1) (Figures 2B and C). The EdU labeling fre-
quency peaked on P7 (17.3% ± 3.1%) (ANOVA, p < 0.001,
post hoc, Holm-Sidak, p < 0.001), followed by a continuous
decline to ratios of less than 1% on P15. On P100, we identified
only one EdU-labeled cardiomyocyte nucleus among 980
analyzed nuclei (Figure 2C). Next, we investigated the distribu-
tion of EdU incorporation into mono- and multinucleated cardi-
omyocytes (Figures 2B and 2D). In agreement with cardiomyo-
cyte proliferation, EdU incorporation was predominantly
observed in mononucleated cardiomyocytes on P3 (95.8% ±
1.9%) and rapidly changed during the first postnatal week
(P7), when most EdU-labeled cardiomyocytes became binucle-
ated (mononucleated: 7.3% ± 3.5%, binucleated: 88.7% ±
5.2%, and multinucleated: 4.0% ± 2.2%) (Figure 2D). Our data
support a previous report suggesting an early postnatal switch
from cardiomyocyte proliferation to multinucleation (Soonpaa
et al., 1996; Walsh et al., 2010).
Cardiomyocyte DNA Content Increases during the
Second and Third Postnatal Weeks
Many cardiomyocyte nuclei undergo DNA synthesis to become
polyploid in humans (Adler, 1991; Bergmann et al., 2009; Herget1028 Cell 163, 1026–1036, November 5, 2015 ª2015 Elsevier Inc.et al., 1997; Mollova et al., 2013). However, ploidy changes in ju-
venile mouse hearts have not been systematically investigated.
We therefore determined the DNA content of murine cardiomyo-
cyte nuclei on different postnatal days by flow cytometry (Figures
3A to 3D, and S2). Most cardiomyocyte nuclei were diploid
around birth until P9 (Figures 3C, left, and S2), corresponding
to 104.7% ± 0.4% in Figure 3D. Between postnatal weeks 2
and 3, the average DNA content per nucleus increased by
approximately 10% in the left ventricle (Figures 3C, right, and
S2) to 115.5% ± 2.3% (Figure 3D, ANOVA p < 0.001) and re-
mained constant thereafter until P100 (Figure 3D). This finding
is also reflected by an increase in the ploidy of the EdU-labeled
cardiomyocyte nuclei between P3 and P13 (Figures 3E and 3F).
Cardiomyocytes Exhibit No Enhanced Cell-Cycle
Activity in Preadolescent Mice
Ki-67 is expressed in all phases of the cell cycle including mitotic
events (Scholzen and Gerdes, 2000). Thus, we used Ki-67 to
exclude substantial cell-cycle activity on P14 and P15 as
described by Naqvi et al. (2014). We sacrificed postnatal mice
on P14 at 9:00 p.m., on P15 at noon, and on P16 at 9:00 a.m.
The shorter length of our analysis intervals (14 hr and 21 hr)
compared to the average mammalian cell-cycle length of
approximately 24 hr (Hahn et al., 2009; Ponti et al., 2013) would
allow us to detect any cell-cycle activity on P15. However, we
could not detect any significant difference between P14, P15,
and P16 (Holm-Sidak method, p > 0.05). By contrast, we
observed that these three time points all exhibited Ki-67 fre-
quencies of less than 2% compared to that on P7 (ANOVA, p <
0.001) (Figures 4A and 4B).
PCM-1 disassembles in pro-metaphase and metaphase of
mitosis (Srsen et al., 2009). Although PCM-1 can be detected
in all other phases of the cell cycle, we excluded the possibility
that we underestimated the number of cycling cardiomyocytes
by also using antibodies against cardiac troponin I to identify car-
diomyocyte nuclei by their location in the cardiomyocyte cyto-
plasm (Figure 4B).
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Figure 3. Cardiomyocyte Nuclear Ploidy in the Growing Mouse Heart
(A and B) Cardiomyocyte nuclei were labeled with isotype controls (A) and antibodies against PCM-1 (B).
(C) Two representative flow cytometry histograms depict the DNA content of cardiomyocyte nuclei (PCM-1-positive) from P7 and P18 mice.
(D) Time course of the cardiomyocyte DNA content per nucleus. Cardiomyocyte nuclei undergo polyploidization during the second and third postnatal weeks
(95% confidence interval [blue], 95% prediction interval [red]; 100% corresponds to a pure diploid population [2n], and 200% to a pure tetraploid population [4n]).
(E and F) Flow cytometric analysis of the EdU-positive cardiomyocyte nuclear ploidy (see Figure 2A for the time course of EdU injection). (E) Representative flow
cytometry plots for immunolabeling of P7 animals with antibodies against PCM-1 and EdU detection (PCM-1+/EdU+). Note that the different fluorescent in-
tensities within the EdU-positive populations indicate different levels of EdU incorporation. Cells may have gone through the S-phase twice after BrdU was
delivered. Lower left: flow cytometry plots with isotype control antibodies and without EdU detection; upper left: flow cytometry plots with PCM-1 antibodies and
without EdU detection.
(F) The nuclear ploidy of EdU-positive cardiomyocyte nuclei measured at different time points (P3 to P13). The nuclear ploidy began to increase on P9. 2n: diploid;
4n: tetraploid; SSC: side scatter.
All error bars indicate SD.BrdU IncorporationRevealsOnlyMinimal DNASynthesis
in Preadolescent Cardiomyocytes
Naqvi et al. proposed a highly synchronized last round of cardi-
omyocyte proliferation beginning on the evening of P14. Thymi-
dine analogs such as BrdU have a short biological half-life.
Therefore, it might be difficult to detect the suggested cardio-
myocyte DNA synthesis on P15 with a single BrdU injection.
Consequently, we subcutaneously implanted a pellet on P13
that continuously released BrdU (Experimental Procedures and
Figures 4C to 4I). BrdU incorporation into cardiomyocyte nuclei
(PCM-1-positive) was detected by immunohistochemistry (IHC)
(Figures 4D and 4E) and flow cytometry on P18 (Figures 4F to
4H). Both experimental strategies revealed a BrdU incorporation
rate of less than 3% in cardiomyocyte nuclei (IHC: 1.8% ± 0.9%;
flow cytometry: 2.9% ± 1.4%) (Figure 4I). An analysis of the DNA
content in BrdU-positive nuclei revealed an increase in nuclear
ploidy in cardiomyocytes compared to non-cardiomyocytes
(Figure 4H). These findings exclude the possibility of amajor pro-
liferative cardiomyocyte burst between P13 and P18. By
contrast, the majority of BrdU-positive cardiomyocyte nuclei
were tetraploid, indicating that DNA synthesis is linked to poly-
ploidization rather than proliferation after P13 (also see Figure 3).
Furthermore, we did not observe any differences in the BrdU la-
beling frequency of endocardial (1.4% ± 0.4%) or epicardial car-diomyocyte (1.3% ± 0.6%) nuclei (paired t test, p = 0.93) (Figures
4D and S3).
Multi-Isotope Mass Spectrometry Analyses of 15N
Thymidine Incorporation Provide No Evidence of a
Second Wave of Cardiomyocyte Proliferation in
Preadolescent Mice
We continuously administered 15N-thymidine (Experimental
Procedures) in preadolescent mouse hearts (P13–P23) (Fig-
ure 5A) to exclude the possibility that continuous delivery of
the halogenated thymidine analogs (BrdU or EdU) might be
associated with toxic effects that alter cell turnover (Andersen
et al., 2013; Wilson et al., 2008). Nonradioactive stable isotope
tracers such as 15N-thymidine do not alter biochemical reac-
tions and are not harmful to the animal (Steinhauser et al.,
2012). Multi-isotope imaging mass spectrometry (MIMS) allows
the simultaneous detection of the stable isotopes of the same
element (Senyo et al., 2013). Due to the low natural abundance
of 15N (0.37%), the incorporation of a 15N-labeled tracer is
readily detected due to an increase in the 15N:14N ratio.
Because DNA contains a high amount of phosphate, we also
visualized phosphorus (31P) in addition to the 15N:14N ratio to
identify cardiac nuclei with high spatial resolution (Figures 5B
to 5D). At a lateral resolution of less than 100 nm,Cell 163, 1026–1036, November 5, 2015 ª2015 Elsevier Inc. 1029
cardiomyocytes were identified based on the cell borders and
their subcellular specific ultrastructure, allowing the identifica-
tion of cardiomyocyte nuclei based on their location (Figures
5B to 5D). The nuclear 15N integration was evenly distributed
throughout the investigated myocardium (Figure S4). In addition
to analyzing 15N thymidine incorporation on sections, we iso-
lated cardiomyocyte nuclei by flow cytometry (as shown in Fig-
ure 3A and 3B), and determined 15N thymidine incorporation
subsequently (Figure 5E). In both experimental designs we
observed 15N-thymidine incorporation in only a small fraction
of cardiomyocyte nuclei between P13 and P23 (0.9% to 2.1%)
(t test, p > 0.05) (Figures 5B to 5F), comparable to the data
obtained by BrdU infusion (Figures 4C to 4I) and not compatible
with the robust cardiomyocyte proliferation suggested by
Naqvi et al.
An Integrated Model of DNA Synthesis in Postnatal
Cardiomyocytes
Based on our data obtained by design-based stereology (Fig-
ures 1A to 1E) and by flow cytometric analysis (Figure 3D), we es-
tablished a quantitative model of DNA synthesis in postnatal car-
diomyocytes (Figures 6A to 6C). Cardiomyocyte proliferation is
highest at birth, followed by a phase of multinucleation reaching
a maximum around P7. The polyploidization of cardiomyocyte
nuclei reflects the last wave of DNA synthesis, peaking around
P14 (Figure 6B). Derivative graphs depicting the DNA content
changes per time unit were calculated based on absolute quan-
tifications of cardiomyocyte nucleus number (Figure 1C), cardio-
myocyte ploidy (Figure 3D), and cardiomyocyte number
(Figure 1E) without relying on markers of proliferation or the
incorporation of thymidine analogs with unknown biological
half-lives. As the number of cardiomyocytes and number of car-
diomyocyte nuclei substantially changes postnataly, we used
the time of birth as a reference for calculating postnatal DNA syn-
thesis. Multinucleation accounted for 57% of the total postnatal
DNA synthesis, cardiomyocyte number expansion was related to
30%, and polyploidization reflected 13% of this synthesis,
mainly in the second and third postnatal weeks (areas under
the curves, see Figure 6).
DISCUSSION
The postnatal heart has a robust capability to generate new
myocardium after apical dissection and injury, although whether
inducedmyocardiogenesis leads to complete myocardial regen-
eration remains controversial (Andersen et al., 2014; Jesty et al.,
2012; Mahmoud et al., 2013; Sadek et al., 2014). Until recently,
whether neonatal myocardiogenesis is a physiological phenom-
enon or whether injury is required to initiate substantial cardio-
myocyte proliferation has been unknown. We demonstrated
that, even in the uninjured neonatal heart, a substantial number
of cardiomyocytes are generated within the first postnatal
week, in agreement with the report by Naqvi et al. (Naqvi et al.,
2014). However, by several distinct approaches, we failed to
observe any substantial increase in the cardiomyocyte number
or proliferation rate between P13 and P100.
We first used design-based stereology to establish the cardi-
omyocyte cell count in the left ventricle. Stereology is a powerful1030 Cell 163, 1026–1036, November 5, 2015 ª2015 Elsevier Inc.tool to obtain unbiased estimates of cell and nucleus numbers in
different organ systems (Bergmann et al., 2015; Yeung et al.,
2014). This technique relies on the accurate identification of
cardiomyocyte nuclei; we and others have successfully utilized
pericentriolar material 1 (PCM-1) as a specific marker for cardio-
myocyte nuclei (Bergmann and Jovinge, 2012; Bergmann et al.,
2011; Bergmann et al., 2015; Gilsbach et al., 2014; Preissl et al.,
2015). In contrast to cell isolation strategies, stereological esti-
mates are not dependent on isolation efficiency. Even with the
most efficient method, retrograde perfusion using a Langendorff
system, the expected yield of cardiomyocytes is never 100%
and varies between 1.5 and 2.5 million in mice (older than
P17) (Naqvi et al., 2014). Our cardiomyocyte number estimate
is supported by previous studies that reported similar number
of cardiomyocyte nuclei and cardiomyocyte nucleus density in
young adult mice (Adler et al., 1996; Bersell et al., 2009). Taking
our stereological estimation as a reference for the cardiomyo-
cyte count (Figure 1E), Naqvi et al. cardiomyocyte isolation effi-
ciency is estimated to be only 50% to 65% depending on the
analyzed time points (Figures S1D and S1E). Because the
amount and composition of the extracellular matrix changes
dramatically in growing hearts (Anderson, 2010), it is likely that
the reported cardiomyocyte increase between P15 and P17
could, at least in part, be explained by age-dependent differ-
ences in the cardiomyocyte isolation efficiencies. In this case,
already changes in isolation efficiency of 15%–20% could
explain the discrepancy between Naqvi et al. and our data (Fig-
ures S1D and S1E).
We performed Ki-67 staining on P14, P15, and P16 and ob-
tained no evidence of extensive cardiomyocyte proliferation
(<2% labeling frequency). By contrast, we observed that up to
13% of cardiomyocytes were in the cell cycle on P7, when
most multinucleation occurs. Ki-67 expression is not restricted
to mitosis but can be detected in all cell-cycle stages (G1, S,
G2, and mitosis). For a cell-cycle length of approximately 24 hr
(Hahn et al., 2009; Ponti et al., 2013), an extensive burst of
proliferation would have been readily detected by this labeling
strategy. One of the major caveats of Naqvi et al. immunohisto-
chemistry approaches is the lack of a nuclear marker to unequiv-
ocally identify cardiomyocytes as discussed above. Without us-
ing a cardiomyocyte nuclear marker, it is difficult to distinguish
cardiomyocyte from non-cardiomyocytes (Ang et al., 2010),
particular in growing hearts in which the nucleus density can
be more than 10-times higher than in the adult hearts (Bergmann
et al., 2015). It is our impression that the provided images in
Naqvi et al. do not allow an accurate discrimination between car-
diomyocytes and non-cardiomyocytes being aurora B-positive
(see Naqvi et al., Figures 3B, S2, and S3). Moreover, Naqvi
et al. reported that approximately 30% of isolated cardiomyo-
cytes are positive for aurora B (compared to 15% measured in
tissue sections). This labeling frequency even exceeds mitotic
rates in embryonic hearts by far (embryonic day 14.5: 13.9% in
G2/M phase) (Walsh et al., 2010). The measured high aurora B
frequency of 30% in the cardiomyocyte compartment would
result in an even more dramatic increase in the number of cardi-
omyocytes than reported by Naqvi et al. (22% based on Langen-
dorff preparation on P15). Given the estimated short duration of
mitosis (approx. 1.8 hr in ventricular cardiomyocytes) (Mollova
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et al., 2013), 30% of mitotic cardiomyocytes in this four-hour
window would translate to an expansion of the cardiomyocyte
compartment by 67% (30% 3 4 hr/1.8 hr). Therefore, it seems
reasonable to assume that Naqvi et al. have substantially overes-
timated the number of aurora B-positive cardiomyocytes in their
study.
One of the most prevalent techniques for detecting cell prolif-
eration is the administration and immunohistochemical detection
of thymidine analogs such as BrdU or EdU. EdU injection in the
afternoon on P13 and P14 resulted in a fraction of less than 1%
labeled cardiomyocyte nuclei when analyzed on P15 (Figure 2C).
However, given the relatively short biological half-life of thymi-
dine analogs, a highly synchronized proliferation of cardiomyo-
cytes on P14 and P15 could go undetected. Therefore, we
continuously administered BrdU by implanting a subcutaneous
pellet on P13. In agreement with our other results, less than 3%
of all cardiomyocyte nuclei had incorporated BrdU on P18 (Fig-
ure 4I), which is not compatible with the 40% increase in the car-
diomyocyte cell number reported by Naqvi et al. We were also
unable to confirm the regional differences in cardiomyocyte pro-
liferation (epicardial versus endocardial regions) suggested by
Naqvi et al. (Figure 4D). Furthermore, the BrdU-labeled cardio-
myocyte nuclei between P13 and P18 were mainly tetraploid
(Figure 4H), indicating that the majority of DNA synthesis after
P13 can be attributed to polyploidization and not proliferation.
In contrast to our present study, Naqvi et al. performed a single
BrdU pulse on the night of P14, which was sufficient to label a
substantially larger fraction (11.3%) than detected by us of
mainly diploid cardiomyocyte nuclei after a chase period of
4 days. Although, their BrdU pulse-chase experiments do not
support the reported 40% increase in the cardiomyocyte cell
number, their BrdU figure is still several-fold higher than in our
present study. Although it is difficult to draw firm conclusions
without a detailed analysis of primary data, our BrdU data ob-
tained by both flow cytometry and by immunohistochemistry
point to the possibility that Naqvi et al. cardiomyocyte nucleus
isolation strategy was not rigorous enough to sufficiently remove
non-cardiomyocyte nuclei from the analysis.
Because thymidine analogs (e.g., BrdU) induce the prolifera-
tion of hematopoietic stem cells (Wilson et al., 2008) and
mediate toxic effects (Andersen et al., 2013), we continuously
delivered biologically inert 15N thymidine to detect DNA synthe-
sis between P13 and P23 in cardiomyocytes. The labeling fre-
quencies of cardiomyocyte nuclei were consistent with the re-
sults of our previous experiments using BrdU. Less than 3% ofFigure 4. No Evidence for a Peak of Cardiomyocyte Proliferation in Pre
(A–B)Mice were sacrificed on P7, P14 (7 pm), P15 (noon), and on P16 (9.00 am). PC
(n = 3 for all analyzed time points). Cycling cardiomyocytes were identified by Ki-6
black bar depicts the Ki-67 frequency on P15. The scale bar indicates 20 mm.
(C–I) BrdUwas continuously delivered via subcutaneous pellets fromP13 to P18 (E
1-positive) was detected by immunohistochemistry (D, E, and I), and by flow cyto
magnification images (E) revealed BrdU integration into cardiomyocyte (arrow
endocardium. Scale bars: 50 mm in (D) and 10 mm in (E). (F and G) The results of flow
(H) Most BrdU incorporation between P13 and P18 could be detected in tetraploid
The different fluorescence intensities within the BrdU-positive populations indic
S-phase twice after BrdU was delivered. (I) In heart sections (n = 3) and in isolate
BrdU between P13 and P18. By contrast, 15% of all non-cardiomyocyte nucle
All error bars indicate SD.
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preadolescence.
In the present study, we utilized rigorous strategies including
design-based stereology, cell-cycle marker analysis (Ki-67),
EdU pulse chase experiments, and continuous delivery of
BrdU and 15N thymidine. Furthermore, we analyzed cardiomyo-
cyte proliferation both in sections and by flow cytometry without
finding any evidence for a burst of proliferation or a distinct mode
of cell division between P13 and P18. Instead, we observed
completion of cardiomyocyte number expansion no later than
P11. We further demonstrated that young cardiomyocytes
exhibit multinucleation followed by polyploidization as the cells
increase in size.
Cardiomyocytes lose their ability to complete the cell cycle to
increase their number. This loss leads to a progressive restriction
of the cardiomyocyte cell cycle in which cytokinesis is first
exchanged formultinucleation,which in turn is exchanged for pol-
yploidization. In human hearts, the pool of cardiomyocytes and
the degree of multinucleation are established soon after birth
(Bergmann et al., 2015; Mayhew et al., 1997), although one report
has suggested that the cardiomyocyte number increases until
adulthood (Mollova et al., 2013). Polyploidization occurs in both
mouse and human cardiomyocytes, to different degrees. In hu-
mans, approximately 60% of all cardiomyocyte nuclei become
polyploid (Bergmann et al., 2015), whereas only 10% of all cardi-
omyocyte nuclei become polyploid in mice. However, polyploid-
ization occurs after multinucleation at a similar time point in both
species, mostly in preadolescence. Polyploidization occurs
mainly in the second and third postnatal week. Therefore it partly
overlapswithNaqvi et al. suggested increase in thenumberof car-
diomyocytes between P15–P18. However, the limited extent of
polyploidization (approximately 10%) makes it unlikely that Naqvi
et al. has mistaken the moderate ploidy increase for proliferation.
Given the important role of IGF-1 signaling in cardiomyocyte
growth and hypertrophy (Carrasco et al., 2014; Delaughter
et al., 1999), one might speculate that the T3-induced activation
of the IGF-1/IGF-1-R/Akt pathway, as suggested by Naqvi et al.,
mainly triggers hypertrophic cardiomyocyte growth associated
with polyploidization rather than cardiomyocyte proliferation in
preadolescent mice.
We used the C57bl/6N mouse strain, which is a substrain to
the strain (C57bl/6J) used by Naqvi et al. (Naqvi et al., 2014). A
comparison of several strains, including ICR/CD1, C3Heb/FeJ,
C57bl/6BRL, and C57bl/6J showed only little variation regarding
the proliferative capacity and growth in the postnatal mouseadolescent Mice
M-1 (red) and cardiac troponin I (gray) labeling identified cardiomyocyte nuclei
7 (green) expression. Arrows indicate Ki-67-positive cardiomyocyte nuclei. The
xperimental Procedures). BrdU incorporation into cardiomyocyte nuclei (PCM-
metry (F to I). (D) Tile scans of a horizontal section of the mouse heart and high-
s) and non-cardiomyocyte nuclei (arrowheads). Dashed lines indicate the
cytometric analyses of non-BrdU-treatedmice (F) and BrdU-treated mice (G).
cardiomyocyte nuclei, whereas most non-cardiomyocyte nuclei were diploid.
ate different levels of BrdU incorporation. Cells may have gone through the
d cardiac nuclei (n = 4), less than 3% of all cardiomyocyte nuclei incorporated
i incorporated BrdU. * indicates p < 0.05.
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Figure 5. MIMS Analysis of 15N Thymidine
Incorporation in Cardiomyocytes of Pread-
olescent Mice
(A–E) 15N-thymidine was continuously delivered
via a subcutaneous pellet between P13 and P23
(Experimental Procedures). (B to D) Cardiac
nuclei were identified by MIMS-based detection
of 31P, (left) and 14N (middle). Images for 14N
were obtained on the species 12C14N. The 14N
images reveal histological and subcellular details
(cell borders and organelles) and therefore
permit the identification of cardiomyocyte nuclei
(arrows). 15N/14N hue-saturation-intensity images
revealed an increase in the 15N/14N isotope ra-
tios above natural abundances (blue, 0%
excess; red, 300% excess) and therefore indi-
cated 15N-thymidine incorporation into cardiac
nuclei (arrows). (E) 15N thymidine incorporation
in isolated cardiomyocyte nuclei (PCM-1 posi-
tive) by flow cytometry (as shown in Figure 3A
and B). Arrows indicate cardiomyocyte nuclei
with 15N-thymidine incorporation.
(F) Both MIMS strategies revealed that less
than 2.1% of all cardiomyocyte nuclei incorpo-
rated 15N-thymidine between P13 and P23
(n = 6). Images B to D are indexed in Fig-
ure S4A. Scale bars indicate 20 mm. NS: not
significant.
All error bars indicate SD.heart (Haubner et al., 2012; Leu et al., 2001; Porrello et al., 2011;
Soonpaa et al., 1996). Therefore, it is unlikely that genetic differ-
ences in the used substrains can explain the fundamental differ-
ences between our and the Naqvi et al. study.
In summary, the present study demonstrates that the mouse
heart displays a robust generation of cardiomyocytes postna-
tally. In the uninjured neonatal mouse heart, up to 30% of all car-
diomyocytes are generated even after postnatal day 2, and the
full complement of cardiomyocytes (>95%) is reached after
11 days. Thus, there is a strong indication that the neonatal
mouse heart harbor cues the induction of de novo myocardio-
genesis to regenerate the diseased adult heart.Cell 163, 1026–1036, NEXPERIMENTAL PROCEDURES
Animals
Whole litters of five to seven C57BL/6N mice with
confirmed birth dates were used. Size variations
between animals of the same age were minimal
(the mean coefficient of variation was among all
age groups 10%). Whenever possible, littermates
were chosen. For the analysis of mice on post-
natal day 100 only male animals were used.
Mice received EdU (50 mg/kg) by subcutaneous
or intraperitoneal daily injections. BrdU and
15N-thymidine (euriso-top) were delivered contin-
uously (0.5 mg/day corresponds to 60–70 mg/kg/
day) to P13 mice by subcutaneously implanted
pellets (Innovative Research of America, USA),
which were in place for 5 and 10 days, respec-
tively. All procedures were approved by the local
ethics committee. Hearts were removed without
perfusion, and the left ventricle including theseptum was dissected. The wet weight of the heart and the ventricles was
determined with fine scales (±0.1 mg).
Nuclei Isolation
Cardiac nuclei were isolated as described previously (Bergmann et al., 2015).
Frozen heart tissue was dissected and homogenized in lysis buffer (0.32 M su-
crose, 10 mM Tris-HCL [pH 8], 5 mMCaCl2, 5 mMMgAc, 2 mM EDTA, 0.5 mM
EGTA, 1mMDTT) using a T-25Ultra-Turrax probe homogenizer (IKAGermany)
at 24,000 rpm for 10 s, followed by homogenization using a type A pestle in a
40 ml glass douncer (VWR) with eight strokes per sample. The nuclear isolates
were filtered through 100-mm and 60-mm nylon mesh cell strainers (BD Biosci-
ence) and centrifuged at 600 3 g for 10 min. The pellets were dissolved in su-
crose buffer (2.1 M sucrose, 10mMTris-HCl [pH 8], 5 mMMgAc). Finally, 10ml
of sucrose buffer was added to BSA-coated ultracentrifuge tubes and overlaidovember 5, 2015 ª2015 Elsevier Inc. 1033
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Figure 6. Cardiomyocyte DNA Synthesis in
Growing Mouse Hearts
(A–C) The time course and quantification of post-
natal cardiomyocyte DNA synthesis. (B and C)
Cardiomyocyte proliferation, multinucleation, and
polyploidization were observed in the postnatal
murine heart. The magnitude and time course of
the cardiomyocyte number expansion, multi-
nucleation, and polyploidization were related. The
graphs depict the DNA content changes per unit
time based on stereological estimates and flow
cytometric measurements of the cardiomyocyte
number expansion, multinucleation, and poly-
ploidization (Figures 1C to E and Figure 2E). The
changes in DNA synthesis were related to the time
around birth (P2). Diploid nuclei: 2n, tetraploid
nuclei: 4n.with the nuclear isolate. The samples were centrifuged at 13,0003 g for 60min
in a Beckman Avanti Centrifuge (Beckman Coulter), and the nuclear pellets
were dissolved in NSB plus buffer (0.44 M sucrose, 10 mM Tris-HCl [pH
7.2], 70 mM KCl, 10 mM MgCl2, 1.5 mM spermine). All steps were performed
at 4C.
BrdU and EdU Detection by Flow Cytometry
Nuclei were labeled with antibodies against PCM-1 (Santa Cruz, 1:200) over-
night, and PCM-1 was visualized using an appropriate secondary antibody
conjugated to Alexa 488 (Life Technologies). Cardiac nuclei were fixed in
Fix/Perm (BD Biosciences) for 20 min on ice and sorted by flow cytometry
(500,000 per tube) based on a DNA dye (Hoechst 33342). Next, the nuclei
were resuspended in DNase I buffer (20 mM Tris-HCl [pH 8], 2 mM MgCl2,
50 mM KCl) and incubated with 6 U of DNase I (Life Technologies) per 106
nuclei (37C, 30 min). We determined that 6 U of DNase I per 106 nuclei is
optimal for BrdU imaging of murine cardiac nuclei. The nuclei were washed
once with Perm/Wash buffer (BD Biosciences) and resuspended in PBS
(50 ml) for staining with BrdU antibodies conjugated to APC (BD PharMingen,
1:50, 30 min, room temperature). PCM-1 and BrdU incorporation were de-
tected and quantified by flow cytometry. For EdU detection, we used the
Click-iT EDU Alexa Fluor 647 Flow Cytometry Assay kit according to the man-
ufacturer’s instructions (Life Technologies).
MIMS Analysis
Extracted mouse tissue was minced to generate 1-mm3 cubes and immedi-
ately fixed in 2.5% glutaraldehyde and 4% paraformaldehyde in 0.01 M PBS
buffer at pH 7.2 for 2 hr at room temperature. Cardiomyocyte nuclei were iso-
lated by flow cytometry and labeled with antibodies against PCM-1 as
described in Experimental Procedures. Nuclei were transferred to 2.5%glutar-
aldehyde (Sigma) in 0.1 M PBS and stored in a refrigerator. Following standard
electron microscopy embedding protocols, the tissue or the nuclei were post-
fixed in 2%OsO4 in PBS for 1 hr, followed by a ddH20 wash and dehydration in
an ascending alcohol series. Tissue pieces were embedded in Agar 100 resin
(Agar scientific) using propylene oxide as an intermediate agent. The resin was
polymerized at 60C for 48 hr. Thin sections (150 nm) were deposited on clean
silicon chips and introduced into a NanoSIMS-50 ion microprobe (CAMECA,
Gennevilliers, France) operating in scanning mode (Guerquin-Kern et al.,
2005). For the present study, we used a tightly focused Cs+ primary ion
beam, which allowed four secondary ion species (12C, 12C14N, 12C15N
and 31P) to be monitored in parallel from the same sputtered volume. The pri-
mary beam steps over the surface of the sample to create images of the
selected ion species. After careful Cs+ ion implantation to obtain steady-state
ion emission, amosaic view of the tissue over a large areawas generated using
a relatively high-intensity probe with a typical spot size of 200 nm (distance be-
tween 16 and 84% peak intensity from a line scan). The raster size was 80 mm1034 Cell 163, 1026–1036, November 5, 2015 ª2015 Elsevier Inc.with an image definition of 2563 256 pixels and a dwell time of 2 ms per pixel.
These survey images permitted the statistical evaluation of the percentage of
labeled nuclei and enabled the selection of labeled cells for further high-reso-
lution imaging.
High-resolution images were acquired using multiframe mode. The primary
beam intensity was 1 pA with a typical probe size of 100 nm. The raster size
was between 50 and 60 mm to image whole cardiomyocytes with an improved
image definition of 5123 512 pixels. With a dwell time of 2 ms per pixel, up to
20 frames were acquired, and the total analysis time was 2–3 hr. All survey im-
ages and high-resolution images were processed using ImageJ software.
Before calculating local isotopic ratios, each isotopic image was properly
aligned using the TOMOJ plugin (Messaoudii et al., 2007) with 12C14N images
used as a reference before a summed image was obtained for each ion spe-
cies. A 15N:14N ratio map was then established from 12C14N and 12C15N im-
ages based on pixel-by-pixel division. A sample containing no labeled cells
was used as a working reference to adjust the detectors prior to quantification
of the 15N:14N ratios. The final 15N:14N ratio map was displayed using Hue-
Saturation-Intensity (HSI) transformation. These HSI color images were gener-
ated using OpenMIMS, an ImageJ plugin developed by Claude Lechene’s
laboratory (Lechene et al., 2006). The hue corresponds to the ratio value,
and the intensity at a given hue is an index of the statistical reliability.
Stereological Analysis
Using a design-based strategy, tissue pieces (1–2 mm diameter) from the left
ventricle (including the septum) were sampled. Tissues were embedded in 8%
gelatin, and isectors (spheres) with a maximum diameter of 4 mm were pre-
pared to obtain isotropic, uniform random alignment of the samples. The isec-
tors were embedded, and 40-mm-thick cryo sections were stained for stereo-
logical quantitation. Cardiomyocyte nuclei were stained with antibodies
against PCM-1, and nuclei were stained with DRAQ5 (see Immunohistochem-
istry). The analysis was performed on an LSM700 confocal microscope (633
Plan-Apo oil objective) using ZEN2010b software with the NewCast Module
(Visiopharm A/S, version 4.x). A minimum of 3–4 isectors were sampled, and
a minimum of 200 nuclei per animal were counted (1%–2% of the area of
the region of interest). A systematic random sampling scheme (meander sam-
pling) was applied using the optical dissector with a counting frame (40 mm 3
40 mm3 20 mm, and 3 mm guard zones). We defined local vertical areas where
myocytes had been cut along their longitudinal axis to determine the number of
nuclei per myocyte. Myocyte cell borders were labeled with connexin-43 and
dystrophin. Wheat germ agglutinin (WGA) was added to facilitate the identifi-
cation of the cell borders in P2 and P3 animals, and myocyte nuclei were
labeled with PCM-1. To estimate the total numbers of nuclei in the heart, we
utilized the two-step NV3 VREF method (where NV is an estimate of the numer-
ical cell density and VREF is the reference volume of the tissue or organ region
of interest) using an optical dissector (Bru¨el and Nyengaard, 2005). When
necessary, the tissue shrinkage along the z axis was corrected. Tissue
shrinkage along the x and y axes was not observed. The total number of car-
diomyocytes was calculated based on the number of cardiomyocyte nuclei
and the multinucleation level.
Volume Analysis of Isolated Cardiomyocytes
We used an adaptation of the protocol reported by Mollova et al. to assess the
volume of the isolate cardiomyocytes (Mollova et al., 2013). Briefly, frozen
hearts were trimmed to 1-mm3 cubes and fixed in 4% paraformaldehyde at
4C for 2 hr, followed by washing for 2–3 hr in HBSS buffer (Ca2+, Mg2+). The
buffer was exchanged every hour. For cardiomyocyte isolation, collagenase
B (1.8 mg/ml) and collagenase D (2.4 mg/ml) (Roche) were added to the
HBSS buffer (Ca2+, Mg2+), and the tissue pieces were incubated for 12 to
24 hr on a slow shaker at 37C. Isolated cardiomyocytes were concentrated
by spinning at 20 3 g (2 min), stained with WGA conjugated to Alexa 547 (Life
Technologies, 1 mg/ml, 1:500), and mounted with ProLong Gold DAPI (Life
Technologies). The entire procedure beginning with the addition of the collage-
nase was repeated three times. Z-stack images of cardiomyocytes were
obtained using a Zeiss confocal LSM700microscope (633Plan-Apo oil objec-
tive), and the individual cardiomyocyte volume was measured by the Imaris 8
(Bitplane) 3D image processing software program using the surface module.
Immunohistochemistry
Mouse hearts were incubated in sucrose solution (30% Sucrose in PBS) over-
night. The tissue was embedded in Tissue Tek O.C.T. Compound (Sakura) and
frozen in liquid nitrogen. After cryosectioning (25C), 14 mm thick sections
were fixed in 2% formaldehyde for 20 min. For BrdU detection, tissue sections
were incubated in 2N HCl at room temperature for 40 min prior to staining, fol-
lowed by extensive washing with PBS (pH 7.4). Antibodies against BrdU (Ab-
cam, rat 1:250), Ki67-FITC (Abcam, rabbit, SP-6, 1:100), Connexin 43 (Sigma
Aldrich, rabbit, 1:10,000, and Abcam, mouse, 1:200), dystrophin (Atlas Anti-
bodies, rabbit, 1:2,000, and Abcam,mouse, 1:200), PCM-1 (Santa Cruz, rabbit
1:200), MHC (Abcam, mouse, 1:200), and cardiac troponin I (Abcam, mouse,
1:250) were used. The antibodies were visualized using appropriate secondary
antibodies conjugated to Alexa 488, 555 and/or 647 (Life Technologies, 1:500).
WGA conjugated to Alexa 555 and 647 (Life Technologies, 1mg/ml, 1:500) was
used to label the cell borders in P2 and P3 animals. Nuclei were visualized with
DAPI or DRAQ5 (BioStatus), and sections were mounted with ProLong me-
dium (Life Technologies). Image analysis was performed with a Zeiss LSM
700 confocal microscope using ImageJ software.
Statistics
Significant differences between continuous variables were determined by two-
tailed paired and unpaired t tests and ANOVA followed by the post hoc Holm-
Sidak test or by two-tailed t tests with Holm-Bonferroni correction. The data
are presented as means with SD (mean ± SD). Sigma Plot 13.0 was used for
statistical analysis and for dynamic fitting of the data. Derivative graphs of
the cardiomyocyte number, cardiomyocyte nuclear number and ploidy levels
were generated with MathCad 15.0. DNA content changes were determined
compared to the level on P2. p < 0.05 was considered significant.
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